Login / Signup

Correction: CDK4/6 inhibition provides a potent adjunct to Her2-targeted therapies in preclinical breast cancer models.

Agnieszka K WitkiewiczDerek CoxErik S Knudsen
Published in: Genes & cancer (2021)
[This corrects the article DOI: 10.18632/genesandcancer.24.].
Keyphrases
  • cell cycle
  • cell therapy
  • anti inflammatory
  • cell proliferation
  • bone marrow
  • childhood cancer